Factors associated with adherence to guideline-recommended cardiovascular disease prevention among HIV clinicians

Karla I Galaviz1, Jonathan A Colasanti2,3, Ameeta S Kalokhe2,3

  • 1Department of Applied Health Science, Indiana University School of Public Health  Bloomington, Bloomington, IN, USA.

Insights

HIV clinicians

Area of Science:

  • Public Health
  • Cardiology
  • Infectious Diseases

Background:

  • Integrating cardiovascular disease (CVD) prevention into routine human immunodeficiency virus (HIV) care is crucial but challenging.
  • Understanding factors influencing clinician adherence to CVD preventive practices in HIV settings is essential for improving patient outcomes.

Purpose of the Study:

  • To identify factors associated with adherence to guideline-recommended CVD preventive practices among HIV clinicians.
  • To explore the influence of individual, inner setting, and outer setting factors on CVD risk screening and advice provision in HIV care.

Main Methods:

  • An online survey was administered to 38 HIV clinicians across eight clinics in Atlanta.
  • The survey utilized the Consolidated Framework for Implementation Research to assess clinician characteristics, clinic environment, and external factors.
  • Bivariate correlations were used to examine associations between identified factors and guideline adherence for CVD prevention.

Main Results:

  • Clinicians consistently screened for blood pressure, while smoking status and blood glucose screening were also common.
  • Advice provision was frequent for smoking cessation, cholesterol, and blood pressure control.
  • Positive correlations were found between clinician beliefs, motivation, self-efficacy, and peer pressure with adherence to CVD preventive practices.
  • Inner setting factors, such as clinic culture and resources, showed negative correlations with lifestyle-related advice and screening.

Conclusions:

  • Clinician psychosocial characteristics and perceived peer pressure significantly influence adherence to CVD preventive practices in HIV care.
  • Targeting these factors, alongside leadership engagement, may enhance the implementation of CVD prevention strategies within HIV clinics.
  • Further research and targeted interventions are needed to optimize CVD risk management for individuals living with HIV.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
401
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
67
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
53
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
504